オキサリプラチンの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Oxaliplatin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Global Oxaliplatin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025「オキサリプラチンの世界市場 2020年:メーカー別、地域別、種類・用途別」(市場規模、市場予測)調査レポートです。• レポートコード:D0804-09532
• 出版社/出版日:GlobalInfoResearch / 2020年7月
• レポート形態:英文、PDF、134ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医薬品・治療
• 販売価格(消費税別)
  Single User¥382,800 (USD3,480)▷ お問い合わせ
  Multi User¥574,200 (USD5,220)▷ お問い合わせ
  Corporate User¥765,600 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、オキサリプラチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。オキサリプラチンの種類別市場規模(マンニトール、ブドウ糖液、乳糖液、その他)、用途別市場規模(大腸がん、胃がん、卵巣がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Sanofi-Aventis、Mylan、Sun Pharmaceutical、Yakult honsha、Hospira、Dr Reddy's laboratories、Nanjing Pharmaceutical Factory、Fresenius Kabi、Teva、Jiangsu Hengrui Medicine、Luoxin、Hainan Jinrui Pharmaceutical、Jiangsu Aosaikang Pharmaceutical、Chiatai Tianqing、Halfsky Pharmacy、Lunan Pharmaceutical、Qilu Pharmaceutical、Jari Pharmaceutical、YRPG、Hisun Pharmaceutical
・地域別グローバル市場分析 2015年-2020年
・オキサリプラチンの北米市場(アメリカ、カナダ、メキシコ)
・オキサリプラチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・オキサリプラチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・オキサリプラチンの南米市場(ブラジル、アルゼンチン)
・オキサリプラチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:マンニトール、ブドウ糖液、乳糖液、その他
・用途別分析:大腸がん、胃がん、卵巣がん、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Oxaliplatin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Oxaliplatin sales will be xx in 2020 from Oxaliplatin million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Oxaliplatin market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Oxaliplatin industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Oxaliplatin and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Oxaliplatin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oxaliplatin market has been segmented into
Mannitol
Glucose Solution
Lactose Solution
Other

By Application, Oxaliplatin has been segmented into:
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oxaliplatin market presented in the report. This section sheds light on the sales growth of different regional and country-level Oxaliplatin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oxaliplatin market.

The report offers in-depth assessment of the growth and other aspects of the Oxaliplatin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Oxaliplatin Market Share Analysis
Oxaliplatin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oxaliplatin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oxaliplatin sales, revenue and market share for each player covered in this report.

The major players covered in Oxaliplatin are:
Sanofi-Aventis
Mylan
Sun Pharmaceutical
Yakult honsha
Hospira
Dr Reddy’s laboratories
Nanjing Pharmaceutical Factory
Fresenius Kabi
Teva
Jiangsu Hengrui Medicine
Luoxin
Hainan Jinrui Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Chiatai Tianqing
Halfsky Pharmacy
Lunan Pharmaceutical
Qilu Pharmaceutical
Jari Pharmaceutical
YRPG
Hisun Pharmaceutical

Among other players domestic and global, Oxaliplatin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oxaliplatin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oxaliplatin, with price, sales, revenue and global market share of Oxaliplatin in 2018 and 2019.
Chapter 3, the Oxaliplatin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oxaliplatin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oxaliplatin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oxaliplatin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Oxaliplatin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oxaliplatin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Oxaliplatin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Other
1.4 Overview of Global Oxaliplatin Market
1.4.1 Global Oxaliplatin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Oxaliplatin Industry Impact
1.6.1 COVID-19 Potential Implications for the Oxaliplatin
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Oxaliplatin
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Sanofi-Aventis Details
2.1.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi-Aventis SWOT Analysis
2.1.4 Sanofi-Aventis Product and Services
2.1.5 Sanofi-Aventis Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sun Pharmaceutical
2.3.1 Sun Pharmaceutical Details
2.3.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sun Pharmaceutical SWOT Analysis
2.3.4 Sun Pharmaceutical Product and Services
2.3.5 Sun Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Yakult honsha
2.4.1 Yakult honsha Details
2.4.2 Yakult honsha Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Yakult honsha SWOT Analysis
2.4.4 Yakult honsha Product and Services
2.4.5 Yakult honsha Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hospira
2.5.1 Hospira Details
2.5.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hospira SWOT Analysis
2.5.4 Hospira Product and Services
2.5.5 Hospira Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Dr Reddy’s laboratories
2.6.1 Dr Reddy’s laboratories Details
2.6.2 Dr Reddy’s laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Dr Reddy’s laboratories SWOT Analysis
2.6.4 Dr Reddy’s laboratories Product and Services
2.6.5 Dr Reddy’s laboratories Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nanjing Pharmaceutical Factory
2.7.1 Nanjing Pharmaceutical Factory Details
2.7.2 Nanjing Pharmaceutical Factory Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nanjing Pharmaceutical Factory SWOT Analysis
2.7.4 Nanjing Pharmaceutical Factory Product and Services
2.7.5 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fresenius Kabi
2.8.1 Fresenius Kabi Details
2.8.2 Fresenius Kabi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fresenius Kabi SWOT Analysis
2.8.4 Fresenius Kabi Product and Services
2.8.5 Fresenius Kabi Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva SWOT Analysis
2.9.4 Teva Product and Services
2.9.5 Teva Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Jiangsu Hengrui Medicine
2.10.1 Jiangsu Hengrui Medicine Details
2.10.2 Jiangsu Hengrui Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Jiangsu Hengrui Medicine SWOT Analysis
2.10.4 Jiangsu Hengrui Medicine Product and Services
2.10.5 Jiangsu Hengrui Medicine Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Luoxin
2.11.1 Luoxin Details
2.11.2 Luoxin Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Luoxin SWOT Analysis
2.11.4 Luoxin Product and Services
2.11.5 Luoxin Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Hainan Jinrui Pharmaceutical
2.12.1 Hainan Jinrui Pharmaceutical Details
2.12.2 Hainan Jinrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Hainan Jinrui Pharmaceutical SWOT Analysis
2.12.4 Hainan Jinrui Pharmaceutical Product and Services
2.12.5 Hainan Jinrui Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Jiangsu Aosaikang Pharmaceutical
2.13.1 Jiangsu Aosaikang Pharmaceutical Details
2.13.2 Jiangsu Aosaikang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Jiangsu Aosaikang Pharmaceutical SWOT Analysis
2.13.4 Jiangsu Aosaikang Pharmaceutical Product and Services
2.13.5 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Chiatai Tianqing
2.14.1 Chiatai Tianqing Details
2.14.2 Chiatai Tianqing Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Chiatai Tianqing SWOT Analysis
2.14.4 Chiatai Tianqing Product and Services
2.14.5 Chiatai Tianqing Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Halfsky Pharmacy
2.15.1 Halfsky Pharmacy Details
2.15.2 Halfsky Pharmacy Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Halfsky Pharmacy SWOT Analysis
2.15.4 Halfsky Pharmacy Product and Services
2.15.5 Halfsky Pharmacy Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Lunan Pharmaceutical
2.16.1 Lunan Pharmaceutical Details
2.16.2 Lunan Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Lunan Pharmaceutical SWOT Analysis
2.16.4 Lunan Pharmaceutical Product and Services
2.16.5 Lunan Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Qilu Pharmaceutical
2.17.1 Qilu Pharmaceutical Details
2.17.2 Qilu Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Qilu Pharmaceutical SWOT Analysis
2.17.4 Qilu Pharmaceutical Product and Services
2.17.5 Qilu Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Jari Pharmaceutical
2.18.1 Jari Pharmaceutical Details
2.18.2 Jari Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Jari Pharmaceutical SWOT Analysis
2.18.4 Jari Pharmaceutical Product and Services
2.18.5 Jari Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 YRPG
2.19.1 YRPG Details
2.19.2 YRPG Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 YRPG SWOT Analysis
2.19.4 YRPG Product and Services
2.19.5 YRPG Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Hisun Pharmaceutical
2.20.1 Hisun Pharmaceutical Details
2.20.2 Hisun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Hisun Pharmaceutical SWOT Analysis
2.20.4 Hisun Pharmaceutical Product and Services
2.20.5 Hisun Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oxaliplatin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oxaliplatin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oxaliplatin Manufacturer Market Share in 2019
3.3.2 Top 6 Oxaliplatin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oxaliplatin Sales, Revenue and Market Share by Regions
4.1.1 Global Oxaliplatin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oxaliplatin Revenue and Market Share by Regions (2015-2020)
4.2 North America Oxaliplatin Sales and Growth Rate (2015-2020)
4.3 Europe Oxaliplatin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oxaliplatin Sales and Growth Rate (2015-2020)
4.5 South America Oxaliplatin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oxaliplatin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oxaliplatin Sales, Revenue and Market Share by Country
5.1.1 North America Oxaliplatin Sales and Market Share by Country (2015-2020)
5.1.2 North America Oxaliplatin Revenue and Market Share by Country (2015-2020)
5.2 United States Oxaliplatin Sales and Growth Rate (2015-2020)
5.3 Canada Oxaliplatin Sales and Growth Rate (2015-2020)
5.4 Mexico Oxaliplatin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oxaliplatin Sales, Revenue and Market Share by Country
6.1.1 Europe Oxaliplatin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oxaliplatin Revenue and Market Share by Country (2015-2020)
6.2 Germany Oxaliplatin Sales and Growth Rate (2015-2020)
6.3 UK Oxaliplatin Sales and Growth Rate (2015-2020)
6.4 France Oxaliplatin Sales and Growth Rate (2015-2020)
6.5 Russia Oxaliplatin Sales and Growth Rate (2015-2020)
6.6 Italy Oxaliplatin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oxaliplatin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oxaliplatin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oxaliplatin Revenue and Market Share by Regions (2015-2020)
7.2 China Oxaliplatin Sales and Growth Rate (2015-2020)
7.3 Japan Oxaliplatin Sales and Growth Rate (2015-2020)
7.4 Korea Oxaliplatin Sales and Growth Rate (2015-2020)
7.5 India Oxaliplatin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oxaliplatin Sales and Growth Rate (2015-2020)
7.7 Australia Oxaliplatin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oxaliplatin Sales, Revenue and Market Share by Country
8.1.1 South America Oxaliplatin Sales and Market Share by Country (2015-2020)
8.1.2 South America Oxaliplatin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oxaliplatin Sales and Growth Rate (2015-2020)
8.3 Argentina Oxaliplatin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oxaliplatin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oxaliplatin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oxaliplatin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oxaliplatin Sales and Growth Rate (2015-2020)
9.3 Turkey Oxaliplatin Sales and Growth Rate (2015-2020)
9.4 Egypt Oxaliplatin Sales and Growth Rate (2015-2020)
9.5 South Africa Oxaliplatin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oxaliplatin Sales and Market Share by Type (2015-2020)
10.2 Global Oxaliplatin Revenue and Market Share by Type (2015-2020)
10.3 Global Oxaliplatin Price by Type (2015-2020)
11 Global Oxaliplatin Market Segment by Application
11.1 Global Oxaliplatin Sales Market Share by Application (2015-2020)
11.2 Global Oxaliplatin Revenue Market Share by Application (2015-2020)
11.3 Global Oxaliplatin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oxaliplatin Sales, Revenue and Growth Rate (2021-2025)
12.2 Oxaliplatin Market Forecast by Regions (2021-2025)
12.2.1 North America Oxaliplatin Market Forecast (2021-2025)
12.2.2 Europe Oxaliplatin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oxaliplatin Market Forecast (2021-2025)
12.2.4 South America Oxaliplatin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oxaliplatin Market Forecast (2021-2025)
12.3 Oxaliplatin Market Forecast by Type (2021-2025)
12.3.1 Global Oxaliplatin Sales Forecast by Type (2021-2025)
12.3.2 Global Oxaliplatin Market Share Forecast by Type (2021-2025)
12.4 Oxaliplatin Market Forecast by Application (2021-2025)
12.4.1 Global Oxaliplatin Sales Forecast by Application (2021-2025)
12.4.2 Global Oxaliplatin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Oxaliplatin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oxaliplatin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oxaliplatin Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Oxaliplatin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Aventis Oxaliplatin Major Business
Table 10. Sanofi-Aventis Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 11. Sanofi-Aventis SWOT Analysis
Table 12. Sanofi-Aventis Oxaliplatin Product and Services
Table 13. Sanofi-Aventis Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Mylan Basic Information, Manufacturing Base and Competitors
Table 15. Mylan Oxaliplatin Major Business
Table 16. Mylan Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 17. Mylan SWOT Analysis
Table 18. Mylan Oxaliplatin Product and Services
Table 19. Mylan Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 21. Sun Pharmaceutical Oxaliplatin Major Business
Table 22. Sun Pharmaceutical Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 23. Sun Pharmaceutical SWOT Analysis
Table 24. Sun Pharmaceutical Oxaliplatin Product and Services
Table 25. Sun Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Yakult honsha Basic Information, Manufacturing Base and Competitors
Table 27. Yakult honsha Oxaliplatin Major Business
Table 28. Yakult honsha Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 29. Yakult honsha SWOT Analysis
Table 30. Yakult honsha Oxaliplatin Product and Services
Table 31. Yakult honsha Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Hospira Basic Information, Manufacturing Base and Competitors
Table 33. Hospira Oxaliplatin Major Business
Table 34. Hospira Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 35. Hospira SWOT Analysis
Table 36. Hospira Oxaliplatin Product and Services
Table 37. Hospira Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Dr Reddy's laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Dr Reddy's laboratories Oxaliplatin Major Business
Table 40. Dr Reddy's laboratories Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 41. Dr Reddy's laboratories SWOT Analysis
Table 42. Dr Reddy's laboratories Oxaliplatin Product and Services
Table 43. Dr Reddy's laboratories Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Nanjing Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 45. Nanjing Pharmaceutical Factory Oxaliplatin Major Business
Table 46. Nanjing Pharmaceutical Factory Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 47. Nanjing Pharmaceutical Factory SWOT Analysis
Table 48. Nanjing Pharmaceutical Factory Oxaliplatin Product and Services
Table 49. Nanjing Pharmaceutical Factory Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 51. Fresenius Kabi Oxaliplatin Major Business
Table 52. Fresenius Kabi Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 53. Fresenius Kabi SWOT Analysis
Table 54. Fresenius Kabi Oxaliplatin Product and Services
Table 55. Fresenius Kabi Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Teva Basic Information, Manufacturing Base and Competitors
Table 57. Teva Oxaliplatin Major Business
Table 58. Teva Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 59. Teva SWOT Analysis
Table 60. Teva Oxaliplatin Product and Services
Table 61. Teva Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 63. Jiangsu Hengrui Medicine Oxaliplatin Major Business
Table 64. Jiangsu Hengrui Medicine Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 65. Jiangsu Hengrui Medicine SWOT Analysis
Table 66. Jiangsu Hengrui Medicine Oxaliplatin Product and Services
Table 67. Jiangsu Hengrui Medicine Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Luoxin Basic Information, Manufacturing Base and Competitors
Table 69. Luoxin Oxaliplatin Major Business
Table 70. Luoxin Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 71. Luoxin SWOT Analysis
Table 72. Luoxin Oxaliplatin Product and Services
Table 73. Luoxin Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Hainan Jinrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 75. Hainan Jinrui Pharmaceutical Oxaliplatin Major Business
Table 76. Hainan Jinrui Pharmaceutical Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 77. Hainan Jinrui Pharmaceutical SWOT Analysis
Table 78. Hainan Jinrui Pharmaceutical Oxaliplatin Product and Services
Table 79. Hainan Jinrui Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Jiangsu Aosaikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 81. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Major Business
Table 82. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 83. Jiangsu Aosaikang Pharmaceutical SWOT Analysis
Table 84. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product and Services
Table 85. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Chiatai Tianqing Basic Information, Manufacturing Base and Competitors
Table 87. Chiatai Tianqing Oxaliplatin Major Business
Table 88. Chiatai Tianqing Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 89. Chiatai Tianqing SWOT Analysis
Table 90. Chiatai Tianqing Oxaliplatin Product and Services
Table 91. Chiatai Tianqing Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Halfsky Pharmacy Basic Information, Manufacturing Base and Competitors
Table 93. Halfsky Pharmacy Oxaliplatin Major Business
Table 94. Halfsky Pharmacy Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 95. Halfsky Pharmacy SWOT Analysis
Table 96. Halfsky Pharmacy Oxaliplatin Product and Services
Table 97. Halfsky Pharmacy Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 99. Lunan Pharmaceutical Oxaliplatin Major Business
Table 100. Lunan Pharmaceutical Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 101. Lunan Pharmaceutical SWOT Analysis
Table 102. Lunan Pharmaceutical Oxaliplatin Product and Services
Table 103. Lunan Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 105. Qilu Pharmaceutical Oxaliplatin Major Business
Table 106. Qilu Pharmaceutical Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 107. Qilu Pharmaceutical SWOT Analysis
Table 108. Qilu Pharmaceutical Oxaliplatin Product and Services
Table 109. Qilu Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Jari Pharmaceutical Oxaliplatin Type and Application
Table 111. Jari Pharmaceutical Oxaliplatin Major Business
Table 112. Jari Pharmaceutical Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 113. Jari Pharmaceutical SWOT Analysis
Table 114. Jari Pharmaceutical Oxaliplatin Product and Services
Table 115. Jari Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 116. YRPG Basic Information, Manufacturing Base and Competitors
Table 117. YRPG Oxaliplatin Major Business
Table 118. YRPG Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 119. YRPG SWOT Analysis
Table 120. YRPG Oxaliplatin Product and Services
Table 121. YRPG Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 122. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 123. Hisun Pharmaceutical Oxaliplatin Major Business
Table 124. Hisun Pharmaceutical Oxaliplatin Total Revenue (USD Million) (2018-2019)
Table 125. Hisun Pharmaceutical SWOT Analysis
Table 126. Hisun Pharmaceutical Oxaliplatin Product and Services
Table 127. Hisun Pharmaceutical Oxaliplatin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 128. Global Oxaliplatin Sales by Manufacturer (2018-2019) (MT)
Table 129. Global Oxaliplatin Revenue by Manufacturer (2018-2019) (USD Million)
Table 130. Global Oxaliplatin Sales by Regions (2015-2020) (MT)
Table 131. Global Oxaliplatin Sales Market Share by Regions (2015-2020)
Table 132. Global Oxaliplatin Revenue by Regions (2015-2020) (USD Million)
Table 133. North America Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 134. North America Oxaliplatin Sales Market Share by Countries (2015-2020)
Table 135. North America Oxaliplatin Revenue by Countries (2015-2020) (USD Million)
Table 136. North America Oxaliplatin Revenue Market Share by Countries (2015-2020)
Table 137. Europe Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 138. Europe Oxaliplatin Sales Market Share by Countries (2015-2020)
Table 139. Europe Oxaliplatin Revenue by Countries (2015-2020) (USD Million)
Table 140. Asia-Pacific Oxaliplatin Sales by Regions (2015-2020) (MT)
Table 141. Asia-Pacific Oxaliplatin Sales Market Share by Regions (2015-2020)
Table 142. Asia-Pacific Oxaliplatin Revenue by Regions (2015-2020) (USD Million)
Table 143. South America Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 144. South America Oxaliplatin Sales Market Share by Countries (2015-2020)
Table 145. South America Oxaliplatin Revenue by Countries (2015-2020) (USD Million)
Table 146. South America Oxaliplatin Revenue Market Share by Countries (2015-2020)
Table 147. Middle East & Africa Oxaliplatin Sales by Countries (2015-2020) (MT)
Table 148. Middle East & Africa Oxaliplatin Sales Market Share by Countries (2015-2020)
Table 149. Middle East & Africa Oxaliplatin Revenue by Countries (2015-2020) (USD Million)
Table 150. Middle East & Africa Oxaliplatin Revenue Market Share by Countries (2015-2020)
Table 151. Global Oxaliplatin Sales by Type (2015-2020) (MT)
Table 152. Global Oxaliplatin Sales Share by Type (2015-2020)
Table 153. Global Oxaliplatin Revenue by Type (2015-2020) (USD Million)
Table 154. Global Oxaliplatin Revenue Share by Type (2015-2020)
Table 155. Global Oxaliplatin Sales by Application (2015-2020) (MT)
Table 156. Global Oxaliplatin Sales Share by Application (2015-2020)
Table 157. Global Oxaliplatin Sales Forecast by Regions (2021-2025) (MT)
Table 158. Global Oxaliplatin Market Share Forecast by Regions (2021-2025)
Table 159. Global Oxaliplatin Sales Forecast by Type (2021-2025) (MT)
Table 160. Global Oxaliplatin Market Share Forecast by Type (2021-2025)
Table 161. Global Oxaliplatin Sales Forecast by Application (2021-2025)
Table 162. Global Oxaliplatin Market Share Forecast by Application (2021-2025)
Table 163. Direct Channel Pros & Cons
Table 164. Indirect Channel Pros & Cons
Table 165. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oxaliplatin Picture
Figure 2. Global Sales Market Share of Oxaliplatin by Type in 2019
Figure 3. Mannitol Picture
Figure 4. Glucose Solution Picture
Figure 5. Lactose Solution Picture
Figure 6. Other Picture
Figure 7. Oxaliplatin Sales Market Share by Application in 2018
Figure 8. Colorectal Cancer Picture
Figure 9. Stomach Cancer Picture
Figure 10. Ovarian Cancer Picture
Figure 11. Other Picture
Figure 12. Global Oxaliplatin Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Oxaliplatin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Oxaliplatin Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Oxaliplatin Sales Market Share by Manufacturer in 2019
Figure 33. Global Oxaliplatin Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Oxaliplatin Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Oxaliplatin Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 38. Global Oxaliplatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Oxaliplatin Revenue Market Share by Regions (2015-2020)
Figure 40. Global Oxaliplatin Revenue Market Share by Regions in 2018
Figure 41. North America Oxaliplatin Sales and Growth Rate (2015-2020)
Figure 42. Europe Oxaliplatin Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Oxaliplatin Sales and Growth Rate (2015-2020)
Figure 44. South America Oxaliplatin Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Oxaliplatin Sales and Growth Rate (2015-2020)
Figure 46. North America Oxaliplatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Oxaliplatin Sales Market Share by Countries (2015-2020)
Figure 48. North America Oxaliplatin Sales Market Share by Countries in 2018
Figure 49. North America Oxaliplatin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Oxaliplatin Revenue Market Share by Countries in 2018
Figure 51. United States Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 52. Canada Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 53. Mexico Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 54. Europe Oxaliplatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Oxaliplatin Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Oxaliplatin Revenue Market Share by Countries in 2019
Figure 57. Germany Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 58. UK Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 59. France Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 60. Russia Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 61. Italy Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 62. Asia-Pacific Oxaliplatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Oxaliplatin Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Oxaliplatin Revenue Market Share by Regions 2019
Figure 65. China Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 66. Japan Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 67. Korea Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 68. India Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 69. Southeast Asia Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 70. South America Oxaliplatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Oxaliplatin Sales Market Share by Countries in 2019
Figure 72. South America Oxaliplatin Revenue Market Share by Countries in 2019
Figure 73. Brazil Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 74. Argentina Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 75. Middle East and Africa Oxaliplatin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Oxaliplatin Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Oxaliplatin Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Oxaliplatin Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 80. Egypt Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 81. Turkey Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 82. South Africa Oxaliplatin Sales and Growth Rate (2015-2020) (MT)
Figure 83. Global Oxaliplatin Sales and Growth Rate (2021-2025) (MT)
Figure 84. Global Oxaliplatin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Oxaliplatin Market Forecast (2021-2025) (MT)
Figure 86. Europe Sales Oxaliplatin Market Forecast (2021-2025) (MT)
Figure 87. Asia-Pacific Sales Oxaliplatin Market Forecast (2021-2025) (MT)
Figure 88. South America Sales Oxaliplatin Market Forecast (2021-2025) (MT)
Figure 89. Middle East & Africa Sales Oxaliplatin Market Forecast (2021-2025) (MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel



• 英文レポート名:Global Oxaliplatin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
• 日本語訳:オキサリプラチンの世界市場 2020年:メーカー別、地域別、種類・用途別
• レポートコード:D0804-09532お問い合わせ(見積依頼・ご注文・質問)